RxDoctor Payments Data

Cara Erkut

Psychiatry · Mercer Island, WANPI 1134440266

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $11,750 of the $13,854 with a category attached, or 84.8%. Genentech, Inc. accounts for 84.8% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2021 at $11,750 and has fallen 88.5% since, to $1,351 in 2025. Among psychiatry clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,854in general payments, 2019–2025

Across 106 payments — averaging $130.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$12K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$526
  • AbbVie$424
  • Otsuka America Pharmaceutical, Inc.$202
  • Johnson & Johnson$198
  • Neurocrine Biosciences, Inc.$152
  • plus $602 from 12 others

What the payments were for

  • Consulting fees$11,75085%
  • Food & beverage$2,05715%
  • Education$470%

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$13,854 in reported general payments places this provider in the 95th percentile of 576 psychiatry providers in Washington.

See all psychiatry providers in Washington

Most prescribed under Part D

DrugClaimsCost to plans & patients
Quetiapine Fumarate16$58

Paid to pharmacies, not to this prescriber.

Other psychiatry in Mercer Island

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →